Research Paper
microRNA-212 inhibits nasopharyngeal carcinoma progression through targeting TPD52 and inhibiting EMT and Wnt/β-catenin pathway
Figure 7. MiR-212 inhibited tumor growth in vivo. (A) Tumor volume growth curve. n=6. (B) The expression of TPD52 and Wnt/β-catenin were detected by western blot. n=6. (C) The proliferation and angiogenesis of tumor tissue section as detected by Ki-67 and CD31 immunostaining, respectively. Representative images were shown. * p < 0.05; ** p < 0.01.